Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 25-Jan-24 6:13 AM View:  | Phathom Pharmaceuticals, Inc. (PHAT) | 24-Jan-24 | Sale | 3,703,700 | $8.10 | $30,000,000.00 | (50%) 7.46M to 3.76M | |
| 01-Dec-22 5:47 PM View: | Hillevax, Inc. (HLVX) | 30-Nov-22 | Exercise (in-the money or at-the-money) | 5,883,500 | -- | -- | 700% 840.5K to 6.72M | |
| 06-Jul-22 6:28 AM View: | Ovid Therapeutics Inc. (OVID) | 01-Jul-22 | Acquisition (other) | 5,750,000 | -- | -- | 76% 7.53M to 13.28M | |
| 06-Jul-22 6:28 AM View: | Ovid Therapeutics Inc. (OVID) | 01-Jul-22 | Disposition (other) | 5,750,000 | -- | -- | (43%) 13.28M to 7.53M | |
| 16-Mar-22 8:10 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 14-Mar-22 | Sale | 18 | $19.00 | $342.00 | (< 1%) 7.46M to 7.46M | |
| 16-Mar-22 8:10 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 14-Mar-22 | Exercise (in-the money or at-the-money) | 7,359,300 | -- | -- | 7359% 100.0K to 7.46M | |
| 09-Dec-21 6:04 AM View: | Day One Biopharmaceuticals,... (DAWN) | 08-Dec-21 | Market Sale | 110,338 | $18.03 | $1,989,390.00 | (2%) 6.23M to 6.12M | < 1% |
| 09-Dec-21 6:04 AM View: | Day One Biopharmaceuticals,... (DAWN) | 07-Dec-21 | Market Sale | 186,935 | $18.76 | $3,507,480.00 | (3%) 6.42M to 6.23M | 4% |
| 07-Dec-21 6:01 AM View: | Day One Biopharmaceuticals,... (DAWN) | 06-Dec-21 | Market Sale | 97,692 | $18.05 | $1,763,340.00 | (1%) 6.52M to 6.42M | < 1% |
| 07-Dec-21 6:01 AM View: | Day One Biopharmaceuticals,... (DAWN) | 03-Dec-21 | Market Sale | 12,517 | $18.47 | $231,189.00 | (< 1%) 6.53M to 6.52M | 3% |
| 29-Nov-21 5:16 PM View: | Day One Biopharmaceuticals,... (DAWN) | 24-Nov-21 | Acquisition (other) | 57,224 | -- | -- | < 1% 6.47M to 6.53M | |
| 08-Nov-21 6:04 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 04-Nov-21 | Sale | 1,000,000 | $20.85 | $20,850,000.00 | (91%) 1.1M to 100.0K | |
| 08-Nov-21 6:04 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 04-Nov-21 | Exercise (in-the money or at-the-money) | 228,696 | -- | -- | 26% 871.3K to 1.1M | |
| 26-Oct-21 8:31 PM View: | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 1,475,120 | -- | -- | 100% 0 to 1.48M | |
| 15-Oct-21 6:40 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 12-Oct-21 | Conversion | 1,615,430 | -- | -- | 100% 0 to 1.62M | |
| 09-Jul-21 6:09 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 07-Jul-21 | Market Sale (Planned) | 2,609 | $35.05 | $91,445.40 | (< 1%) 873.91K to 871.3K | 3% |
| 06-Jul-21 6:10 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 02-Jul-21 | Market Sale (Planned) | 100 | $35.01 | $3,501.00 | (< 1%) 874.01K to 873.91K | < 1% |
| 06-Jul-21 6:10 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Jul-21 | Market Sale (Planned) | 8,226 | $35.16 | $289,226.00 | (< 1%) 882.24K to 874.01K | 1% |
| 29-Jun-21 6:44 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 28-Jun-21 | Market Sale (Planned) | 370 | $35.08 | $12,979.60 | (< 1%) 882.61K to 882.24K | 2% |
| 29-Jun-21 6:44 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 25-Jun-21 | Market Sale (Planned) | 24,131 | $35.49 | $856,448.00 | (3%) 906.74K to 882.61K | 3% |
| 25-Jun-21 7:27 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 24-Jun-21 | Market Sale (Planned) | 10,848 | $35.14 | $381,199.00 | (1%) 917.59K to 906.74K | < 1% |
| 25-Jun-21 7:27 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 23-Jun-21 | Market Sale (Planned) | 200 | $35.00 | $7,000.00 | (< 1%) 917.79K to 917.59K | (< 1%) |
| 23-Jun-21 6:15 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 22-Jun-21 | Market Sale (Planned) | 100 | $35.00 | $3,500.00 | (< 1%) 917.89K to 917.79K | 3% |
| 23-Jun-21 6:15 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 21-Jun-21 | Market Sale (Planned) | 9,294 | $35.31 | $328,171.00 | (1%) 927.18K to 917.89K | 4% |
| 21-Jun-21 6:10 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 18-Jun-21 | Market Sale (Planned) | 5,398 | $35.13 | $189,632.00 | (< 1%) 932.58K to 927.18K | < 1% |
| 21-Jun-21 6:10 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 17-Jun-21 | Market Sale (Planned) | 3,305 | $35.08 | $115,939.00 | (< 1%) 935.89K to 932.58K | < 1% |
| 16-Jun-21 6:06 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 14-Jun-21 | Market Sale (Planned) | 2,826 | $35.06 | $99,079.60 | (< 1%) 938.71K to 935.89K | 5% |
| 11-Jun-21 6:09 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 10-Jun-21 | Market Sale (Planned) | 2,102 | $35.14 | $73,864.30 | (< 1%) 940.81K to 938.71K | < 1% |
| 11-Jun-21 6:09 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 09-Jun-21 | Market Sale (Planned) | 1,191 | $35.28 | $42,018.50 | (< 1%) 942.0K to 940.81K | 1% |
| 09-Jun-21 6:41 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 08-Jun-21 | Market Sale (Planned) | 100 | $35.00 | $3,500.00 | (< 1%) 942.11K to 942.0K | < 1% |
| 09-Jun-21 6:41 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 07-Jun-21 | Market Sale (Planned) | 2,264 | $35.05 | $79,353.20 | (< 1%) 944.37K to 942.11K | < 1% |
| 04-Jun-21 6:23 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 02-Jun-21 | Market Sale (Planned) | 4,300 | $35.18 | $151,274.00 | (< 1%) 948.67K to 944.37K | 6% |
| 02-Jun-21 6:08 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 01-Jun-21 | Market Sale (Planned) | 11,211 | $35.78 | $401,130.00 | (1%) 959.88K to 948.67K | (< 1%) |
| 02-Jun-21 6:08 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 28-May-21 | Market Sale (Planned) | 8,905 | $36.19 | $322,305.00 | (< 1%) 968.78K to 959.88K | < 1% |
| 28-May-21 6:11 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 27-May-21 | Market Sale (Planned) | 8,453 | $37.14 | $313,953.00 | (< 1%) 977.24K to 968.78K | < 1% |
| 28-May-21 6:11 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 26-May-21 | Market Sale (Planned) | 12,358 | $36.64 | $452,747.00 | (1%) 989.6K to 977.24K | (1%) |
| 26-May-21 9:42 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-21 | Market Sale (Planned) | 10,947 | $36.18 | $396,079.00 | (1%) 1.0M to 989.6K | (< 1%) |
| 26-May-21 9:42 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 24-May-21 | Market Sale (Planned) | 10,594 | $35.66 | $377,810.00 | (1%) 1.01M to 1.0M | (2%) |
| 24-May-21 6:24 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 21-May-21 | Market Sale (Planned) | 11,648 | $35.74 | $416,300.00 | (1%) 1.02M to 1.01M | < 1% |
| 24-May-21 6:24 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 20-May-21 | Market Sale (Planned) | 7,098 | $35.10 | $249,140.00 | (< 1%) 1.03M to 1.02M | (1%) |
| 18-May-21 6:02 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 14-May-21 | Market Sale (Planned) | 100 | $35.00 | $3,500.00 | (< 1%) 1.03M to 1.03M | 4% |
| 14-May-21 6:04 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 13-May-21 | Market Sale (Planned) | 100 | $35.33 | $3,533.00 | (< 1%) 1.03M to 1.03M | 4% |
| 14-May-21 6:04 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 12-May-21 | Market Sale (Planned) | 11,776 | $35.44 | $417,359.00 | (1%) 1.04M to 1.03M | 4% |
| 11-May-21 6:30 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 07-May-21 | Market Sale (Planned) | 1,011 | $35.03 | $35,415.30 | (< 1%) 1.04M to 1.04M | 6% |
| 07-May-21 7:22 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 06-May-21 | Market Sale (Planned) | 202 | $35.01 | $7,072.02 | (< 1%) 1.04M to 1.04M | 4% |
| 07-May-21 7:22 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 05-May-21 | Market Sale (Planned) | 6,936 | $35.14 | $243,731.00 | (< 1%) 1.05M to 1.04M | 4% |
| 05-May-21 8:26 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 04-May-21 | Market Sale (Planned) | 19,360 | $36.04 | $697,808.00 | (2%) 1.07M to 1.05M | < 1% |
| 05-May-21 8:26 AM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 03-May-21 | Market Sale (Planned) | 14,632 | $38.28 | $560,041.00 | (1%) 1.08M to 1.07M | 6% |
| 22-Nov-19 6:23 AM View: | Ovid Therapeutics Inc. (OVID) | 08-Oct-19 | Market Purchase | 2,000,000 | $2.50 | $5,000,000.00 | 53% 3.75M to 5.75M | 50% |